Clinical Trial Update: Romiplostim N01 in the Treatment of Thrombocytopenia Caused by Cytotoxic Drugs in Breast Cancer Patients [NA]

View source ↗

Summary

A clinical trial investigating Romiplostim N01 for thrombocytopenia caused by cytotoxic chemotherapy in breast cancer patients; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Thrombocytopenia

Drugs mentioned

• Romiplostim N01 (romiplostim)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Cytotoxic Drugs, Romiplostim N01 | NA | Status: NOT_YET_RECRUITING